For GLP-1 analogues, computational chemistry can screen peptide modifications, predict half-life extension strategies (e.g., albumin binding, acylation), and model receptor conformational changes
(2024) 36:13021319 e1312
Bioorg Med Chem 94:117479
4,6 A key issue in the physiology of type 2 diabetes (T2DM) is the reduced incretin effect, which mainly results from decreased activity of the primary incretin hormones, GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic peptide)
Because tirzepatide adds a second receptor (GIP), many patients who plateaued on a GLP-1-only drug see renewed progress after switching, under provider supervision
Whether you're looking to expand your treatment menu, introduce wellness services into your clinic or begin offering injectable vitamin therapies, this course provides a comprehensive introduction to one of the most accessible and profitable treatments available